ImmunityBio

These results provide compelling evidence of the need for vaccines to target both S and N proteins and to activate T cells to produce immune system memory to combat this virus, Dr. Patrick Soon-Shiong #togetherisbetter #immunotherapy #vaccines #oncology #immunitybio https://immunitybio.com/immunitybios-had5-t-cell-covid-19-/

Capricor Therapeutics, Inc., ImmunityBio and City of Hope make progress on COVID-19 vaccines. As the virus continues to spread at an alarming rate, it is important that we develop Covid-19 vaccines that not only provide the population with protection from new infection through antibodies that block viral entry into cells but also establish a robust T-cell immune response to clear the virus from infected cells, Dr. Patrick Soon-Shiong #togetherisbetter #immunotherapy #biotec...h #vaccines #immunization #medicalsciences #oncology #antibodies https://labusinessjournal.com//capricor-immunitybio-city-/

ImmunityBio's Anktiva is currently being evaluated in late-stage clinical trials in combination with NantKwest (NASDAQ: NK) NK cell therapies for multiple indications including metastatic pancreatic cancer, triple-negative breast cancer (TNBC), bladder cancer, and lung cancer. "We look forward to the continued evaluation of Anktiva as a promising IL-15 superagonist, which may be broadly applied to improve NK cell-based immunotherapies. Dr. Patrick Soon-Shiong, Chairman and CEO. #togetherisbetter #makingadifference #immunotherapy #biotherapeutics #cancerresearch #celltherapy #genetherapy #immunology #oncology

Our Executive Chairman, and CEO, Dr. Patrick Soon-Shiong, weighs in on Pfizer data and discusses the coronavirus vaccine trial process on Fox Business Network. #togetherisbetter #covid19testing #covid19research #immunotherapy #infectiousdiseases #biotechnology #pharmaceutical #research NantKwest

ImmunityBio receives FDA authorization this week to begin Phase l trial of our novel COVID-19 vaccine candidate hAd5. A HUGE Thank You to our team, and to the NantKwest team for their dedication and support. "It is a true testament to the hard work and dedication all of you have committed to this immensely important undertaking. On behalf of the company, and on behalf of all the patients in need, I thank you." Dr. Patrick Soon-Shiong, M.D., Chairmen and CEO #togetherisbetter #togetheragainstcovid19 #immunotherapy #immunitybio #oncology #biotechnology #pharmaceutical #medicine #celltherapy